TriSalus Life Sciences, Inc. TLSI

Updated: 11 Aug 2026

NASDAQ | Biotech | Medical technology and immuno-oncology

No signal published yet

We already track TriSalus Life Sciences and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow TriSalus Life Sciences free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Medical technology and immuno-oncology
We're already tracking TriSalus Life Sciences, Inc. — here are the latest events we've registered

Recent News

  • On August 6, 2026, TriSalus reported second-quarter 2026 revenue of $11.4 million and reiterated its full-year 2026 revenue guidance of $54 million to $57 million. The company also highlighted a July 2026 CMS decision establishing a new G-code that extends reimbursement for the TriNav system into office-based labs.

What Firelda Watch includes for TriSalus Life Sciences, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of TriSalus Life Sciences, Inc. will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Getinge
GETI B
HOLD
Surgical Science Sweden AB (publ)
SUS
HOLD
Vitrolife AB (publ)
VITR
HOLD
Vimian Group AB (publ)
VIMIAN
HOLD
CellaVision AB (publ)
CEVI
HOLD

Biotech

More companies in this sector

Want to follow TriSalus Life Sciences, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow TriSalus Life Sciences free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

TriSalus Life Sciences, Inc. TLSI
TriSalus Life Sciences — follow and we'll monitor it
Follow TriSalus Life Sciences free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.